Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABCL | PCRX | URGN | ||
| Company | Abcellera Biologics Inc | Pacira Pharm Inc | Urogen Pharma Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.72 | 26.04 | 23.50 | ||
| High | 3.72 | 26.63 | 23.71 | ||
| Low | 3.57 | 25.99 | 22.89 | ||
| Latest | 3.58 | 26.51 | 23.03 | ||
| Change | -0.14 | +0.49 | -0.73 | ||
| % Change | -3.76% | +1.88% | -3.07% | ||
| Volume | 2,618,200 | 424,500 | 250,800 | ||
| 20-Day Average Volume | 3,105,540 | 857,190 | 836,855 | ||
| Previous Close | 3.72 | 26.02 | 23.76 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.60 | 25.29 | 23.63 | ||
| 20-Day Raw Stochastic | 48.15% | 83.23% | 20.22% | ||
| 20-Day Relative Strength | 42.65 | 61.70 | 50.34 | ||
| Weighted Alpha | +17.50 | +31.05 | +76.72 | ||
| Today's Opinion | 56% Sell | 56% Buy | 72% Buy | ||
| Previous Opinion | 24% Sell | 56% Buy | 72% Buy | ||
| Last Month's Opinion | 24% Sell | 72% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.42% since 12/18/25 | +2.43% since 12/18/25 | +6.03% since 12/18/25 | ||
| Low | 3.48 on 12/19/25 | 25.56 on 12/24/25 | 21.72 on 12/19/25 | ||
| High | 3.82 on 12/23/25 | 26.99 on 12/22/25 | 24.14 on 12/24/25 | ||
| 1-Month | |||||
| %Chg | -1.65% since 11/26/25 | +11.34% since 11/26/25 | -21.72% since 11/26/25 | ||
| Low | 3.32 on 12/17/25 | 23.28 on 12/01/25 | 21.40 on 12/15/25 | ||
| High | 3.86 on 12/12/25 | 27.16 on 12/16/25 | 29.46 on 11/28/25 | ||
| 3-Month | |||||
| %Chg | -24.47% since 09/26/25 | +5.03% since 09/26/25 | +25.57% since 09/26/25 | ||
| Low | 3.32 on 12/17/25 | 19.84 on 10/21/25 | 15.86 on 10/10/25 | ||
| High | 6.51 on 10/08/25 | 27.16 on 12/16/25 | 30.00 on 11/26/25 | ||
| 6-Month | |||||
| %Chg | -4.28% since 06/26/25 | +11.81% since 06/26/25 | +75.67% since 06/26/25 | ||
| Low | 3.28 on 07/01/25 | 19.84 on 10/21/25 | 12.73 on 07/02/25 | ||
| High | 6.51 on 10/08/25 | 27.64 on 09/03/25 | 30.00 on 11/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,113,526 | 1,119,406 | 1,112,182 | ||
| Shares Outstanding, K | 299,335 | 43,021 | 46,809 | ||
| Annual Sales | 28,830,000 | 700,970,000 | 90,400,000 | ||
| Annual Net Income | -162,860,000 | -99,560,000 | -126,870,000 | ||
| Last Quarter Sales | 8,960,000 | 179,520,000 | 27,480,000 | ||
| Last Quarter Net Income | -57,120,000 | 5,430,000 | -33,350,000 | ||
| 60-Month Beta | 0.73 | 0.23 | 1.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 11/06/25 | 0.70 on 11/06/25 | -0.69 on 11/06/25 | ||
| Latest Earnings Date | 02/26/26 | 02/26/26 | 03/09/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 12.68 | 0.00 | ||